Request for Covid-19 Impact Assessment of this Report
The United States Etoricoxib market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Etoricoxib market, reaching US$ million by the year 2028. As for the Europe Etoricoxib landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Etoricoxib players cover Morepen Laboratories, Merck & Co, Frosst Iberica SA, and Metrochem API, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Etoricoxib market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
30 mg
60 mg
90 mg
120 mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Morepen Laboratories
Merck & Co
Frosst Iberica SA
Metrochem API
Atom Pharma
Hema Pharmaceuticals
Beijing Tide Pharmaceutical
Qilu Pharmaceutical
Shanghai Shyndec Pharmaceutical
Easton Biopharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Etoricoxib Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Etoricoxib by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Etoricoxib by Country/Region, 2017, 2022 & 2028
2.2 Etoricoxib Segment by Type
2.2.1 30 mg
2.2.2 60 mg
2.2.3 90 mg
2.2.4 120 mg
2.3 Etoricoxib Sales by Type
2.3.1 Global Etoricoxib Sales Market Share by Type (2017-2022)
2.3.2 Global Etoricoxib Revenue and Market Share by Type (2017-2022)
2.3.3 Global Etoricoxib Sale Price by Type (2017-2022)
2.4 Etoricoxib Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Others
2.5 Etoricoxib Sales by Application
2.5.1 Global Etoricoxib Sale Market Share by Application (2017-2022)
2.5.2 Global Etoricoxib Revenue and Market Share by Application (2017-2022)
2.5.3 Global Etoricoxib Sale Price by Application (2017-2022)
3 Global Etoricoxib by Company
3.1 Global Etoricoxib Breakdown Data by Company
3.1.1 Global Etoricoxib Annual Sales by Company (2020-2022)
3.1.2 Global Etoricoxib Sales Market Share by Company (2020-2022)
3.2 Global Etoricoxib Annual Revenue by Company (2020-2022)
3.2.1 Global Etoricoxib Revenue by Company (2020-2022)
3.2.2 Global Etoricoxib Revenue Market Share by Company (2020-2022)
3.3 Global Etoricoxib Sale Price by Company
3.4 Key Manufacturers Etoricoxib Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Etoricoxib Product Location Distribution
3.4.2 Players Etoricoxib Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Etoricoxib by Geographic Region
4.1 World Historic Etoricoxib Market Size by Geographic Region (2017-2022)
4.1.1 Global Etoricoxib Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Etoricoxib Annual Revenue by Geographic Region
4.2 World Historic Etoricoxib Market Size by Country/Region (2017-2022)
4.2.1 Global Etoricoxib Annual Sales by Country/Region (2017-2022)
4.2.2 Global Etoricoxib Annual Revenue by Country/Region
4.3 Americas Etoricoxib Sales Growth
4.4 APAC Etoricoxib Sales Growth
4.5 Europe Etoricoxib Sales Growth
4.6 Middle East & Africa Etoricoxib Sales Growth
5 Americas
5.1 Americas Etoricoxib Sales by Country
5.1.1 Americas Etoricoxib Sales by Country (2017-2022)
5.1.2 Americas Etoricoxib Revenue by Country (2017-2022)
5.2 Americas Etoricoxib Sales by Type
5.3 Americas Etoricoxib Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Etoricoxib Sales by Region
6.1.1 APAC Etoricoxib Sales by Region (2017-2022)
6.1.2 APAC Etoricoxib Revenue by Region (2017-2022)
6.2 APAC Etoricoxib Sales by Type
6.3 APAC Etoricoxib Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Etoricoxib by Country
7.1.1 Europe Etoricoxib Sales by Country (2017-2022)
7.1.2 Europe Etoricoxib Revenue by Country (2017-2022)
7.2 Europe Etoricoxib Sales by Type
7.3 Europe Etoricoxib Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Etoricoxib by Country
8.1.1 Middle East & Africa Etoricoxib Sales by Country (2017-2022)
8.1.2 Middle East & Africa Etoricoxib Revenue by Country (2017-2022)
8.2 Middle East & Africa Etoricoxib Sales by Type
8.3 Middle East & Africa Etoricoxib Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Etoricoxib
10.3 Manufacturing Process Analysis of Etoricoxib
10.4 Industry Chain Structure of Etoricoxib
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Etoricoxib Distributors
11.3 Etoricoxib Customer
12 World Forecast Review for Etoricoxib by Geographic Region
12.1 Global Etoricoxib Market Size Forecast by Region
12.1.1 Global Etoricoxib Forecast by Region (2023-2028)
12.1.2 Global Etoricoxib Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Etoricoxib Forecast by Type
12.7 Global Etoricoxib Forecast by Application
13 Key Players Analysis
13.1 Morepen Laboratories
13.1.1 Morepen Laboratories Company Information
13.1.2 Morepen Laboratories Etoricoxib Product Offered
13.1.3 Morepen Laboratories Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Morepen Laboratories Main Business Overview
13.1.5 Morepen Laboratories Latest Developments
13.2 Merck & Co
13.2.1 Merck & Co Company Information
13.2.2 Merck & Co Etoricoxib Product Offered
13.2.3 Merck & Co Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Merck & Co Main Business Overview
13.2.5 Merck & Co Latest Developments
13.3 Frosst Iberica SA
13.3.1 Frosst Iberica SA Company Information
13.3.2 Frosst Iberica SA Etoricoxib Product Offered
13.3.3 Frosst Iberica SA Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Frosst Iberica SA Main Business Overview
13.3.5 Frosst Iberica SA Latest Developments
13.4 Metrochem API
13.4.1 Metrochem API Company Information
13.4.2 Metrochem API Etoricoxib Product Offered
13.4.3 Metrochem API Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Metrochem API Main Business Overview
13.4.5 Metrochem API Latest Developments
13.5 Atom Pharma
13.5.1 Atom Pharma Company Information
13.5.2 Atom Pharma Etoricoxib Product Offered
13.5.3 Atom Pharma Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Atom Pharma Main Business Overview
13.5.5 Atom Pharma Latest Developments
13.6 Hema Pharmaceuticals
13.6.1 Hema Pharmaceuticals Company Information
13.6.2 Hema Pharmaceuticals Etoricoxib Product Offered
13.6.3 Hema Pharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hema Pharmaceuticals Main Business Overview
13.6.5 Hema Pharmaceuticals Latest Developments
13.7 Beijing Tide Pharmaceutical
13.7.1 Beijing Tide Pharmaceutical Company Information
13.7.2 Beijing Tide Pharmaceutical Etoricoxib Product Offered
13.7.3 Beijing Tide Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Beijing Tide Pharmaceutical Main Business Overview
13.7.5 Beijing Tide Pharmaceutical Latest Developments
13.8 Qilu Pharmaceutical
13.8.1 Qilu Pharmaceutical Company Information
13.8.2 Qilu Pharmaceutical Etoricoxib Product Offered
13.8.3 Qilu Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Qilu Pharmaceutical Main Business Overview
13.8.5 Qilu Pharmaceutical Latest Developments
13.9 Shanghai Shyndec Pharmaceutical
13.9.1 Shanghai Shyndec Pharmaceutical Company Information
13.9.2 Shanghai Shyndec Pharmaceutical Etoricoxib Product Offered
13.9.3 Shanghai Shyndec Pharmaceutical Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Shanghai Shyndec Pharmaceutical Main Business Overview
13.9.5 Shanghai Shyndec Pharmaceutical Latest Developments
13.10 Easton Biopharmaceuticals
13.10.1 Easton Biopharmaceuticals Company Information
13.10.2 Easton Biopharmaceuticals Etoricoxib Product Offered
13.10.3 Easton Biopharmaceuticals Etoricoxib Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Easton Biopharmaceuticals Main Business Overview
13.10.5 Easton Biopharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Etoricoxib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Etoricoxib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 30 mg
Table 4. Major Players of 60 mg
Table 5. Major Players of 90 mg
Table 6. Major Players of 120 mg
Table 7. Global Etoricoxib Sales by Type (2017-2022) & (K Units)
Table 8. Global Etoricoxib Sales Market Share by Type (2017-2022)
Table 9. Global Etoricoxib Revenue by Type (2017-2022) & ($ million)
Table 10. Global Etoricoxib Revenue Market Share by Type (2017-2022)
Table 11. Global Etoricoxib Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Etoricoxib Sales by Application (2017-2022) & (K Units)
Table 13. Global Etoricoxib Sales Market Share by Application (2017-2022)
Table 14. Global Etoricoxib Revenue by Application (2017-2022)
Table 15. Global Etoricoxib Revenue Market Share by Application (2017-2022)
Table 16. Global Etoricoxib Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Etoricoxib Sales by Company (2020-2022) & (K Units)
Table 18. Global Etoricoxib Sales Market Share by Company (2020-2022)
Table 19. Global Etoricoxib Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Etoricoxib Revenue Market Share by Company (2020-2022)
Table 21. Global Etoricoxib Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Etoricoxib Producing Area Distribution and Sales Area
Table 23. Players Etoricoxib Products Offered
Table 24. Etoricoxib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Etoricoxib Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Etoricoxib Sales Market Share Geographic Region (2017-2022)
Table 29. Global Etoricoxib Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Etoricoxib Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Etoricoxib Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Etoricoxib Sales Market Share by Country/Region (2017-2022)
Table 33. Global Etoricoxib Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Etoricoxib Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Etoricoxib Sales by Country (2017-2022) & (K Units)
Table 36. Americas Etoricoxib Sales Market Share by Country (2017-2022)
Table 37. Americas Etoricoxib Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Etoricoxib Revenue Market Share by Country (2017-2022)
Table 39. Americas Etoricoxib Sales by Type (2017-2022) & (K Units)
Table 40. Americas Etoricoxib Sales Market Share by Type (2017-2022)
Table 41. Americas Etoricoxib Sales by Application (2017-2022) & (K Units)
Table 42. Americas Etoricoxib Sales Market Share by Application (2017-2022)
Table 43. APAC Etoricoxib Sales by Region (2017-2022) & (K Units)
Table 44. APAC Etoricoxib Sales Market Share by Region (2017-2022)
Table 45. APAC Etoricoxib Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Etoricoxib Revenue Market Share by Region (2017-2022)
Table 47. APAC Etoricoxib Sales by Type (2017-2022) & (K Units)
Table 48. APAC Etoricoxib Sales Market Share by Type (2017-2022)
Table 49. APAC Etoricoxib Sales by Application (2017-2022) & (K Units)
Table 50. APAC Etoricoxib Sales Market Share by Application (2017-2022)
Table 51. Europe Etoricoxib Sales by Country (2017-2022) & (K Units)
Table 52. Europe Etoricoxib Sales Market Share by Country (2017-2022)
Table 53. Europe Etoricoxib Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Etoricoxib Revenue Market Share by Country (2017-2022)
Table 55. Europe Etoricoxib Sales by Type (2017-2022) & (K Units)
Table 56. Europe Etoricoxib Sales Market Share by Type (2017-2022)
Table 57. Europe Etoricoxib Sales by Application (2017-2022) & (K Units)
Table 58. Europe Etoricoxib Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Etoricoxib Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Etoricoxib Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Etoricoxib Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Etoricoxib Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Etoricoxib Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Etoricoxib Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Etoricoxib Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Etoricoxib Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Etoricoxib
Table 68. Key Market Challenges & Risks of Etoricoxib
Table 69. Key Industry Trends of Etoricoxib
Table 70. Etoricoxib Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Etoricoxib Distributors List
Table 73. Etoricoxib Customer List
Table 74. Global Etoricoxib Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Etoricoxib Sales Market Forecast by Region
Table 76. Global Etoricoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Etoricoxib Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Etoricoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Etoricoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Etoricoxib Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Etoricoxib Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Etoricoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Etoricoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Etoricoxib Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Etoricoxib Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Etoricoxib Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Etoricoxib Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Etoricoxib Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Etoricoxib Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Etoricoxib Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Etoricoxib Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Etoricoxib Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Etoricoxib Revenue Market Share Forecast by Application (2023-2028)
Table 94. Morepen Laboratories Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 95. Morepen Laboratories Etoricoxib Product Offered
Table 96. Morepen Laboratories Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Morepen Laboratories Main Business
Table 98. Morepen Laboratories Latest Developments
Table 99. Merck & Co Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 100. Merck & Co Etoricoxib Product Offered
Table 101. Merck & Co Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. Merck & Co Main Business
Table 103. Merck & Co Latest Developments
Table 104. Frosst Iberica SA Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 105. Frosst Iberica SA Etoricoxib Product Offered
Table 106. Frosst Iberica SA Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Frosst Iberica SA Main Business
Table 108. Frosst Iberica SA Latest Developments
Table 109. Metrochem API Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 110. Metrochem API Etoricoxib Product Offered
Table 111. Metrochem API Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Metrochem API Main Business
Table 113. Metrochem API Latest Developments
Table 114. Atom Pharma Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 115. Atom Pharma Etoricoxib Product Offered
Table 116. Atom Pharma Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Atom Pharma Main Business
Table 118. Atom Pharma Latest Developments
Table 119. Hema Pharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 120. Hema Pharmaceuticals Etoricoxib Product Offered
Table 121. Hema Pharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Hema Pharmaceuticals Main Business
Table 123. Hema Pharmaceuticals Latest Developments
Table 124. Beijing Tide Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 125. Beijing Tide Pharmaceutical Etoricoxib Product Offered
Table 126. Beijing Tide Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Beijing Tide Pharmaceutical Main Business
Table 128. Beijing Tide Pharmaceutical Latest Developments
Table 129. Qilu Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 130. Qilu Pharmaceutical Etoricoxib Product Offered
Table 131. Qilu Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Qilu Pharmaceutical Main Business
Table 133. Qilu Pharmaceutical Latest Developments
Table 134. Shanghai Shyndec Pharmaceutical Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 135. Shanghai Shyndec Pharmaceutical Etoricoxib Product Offered
Table 136. Shanghai Shyndec Pharmaceutical Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Shanghai Shyndec Pharmaceutical Main Business
Table 138. Shanghai Shyndec Pharmaceutical Latest Developments
Table 139. Easton Biopharmaceuticals Basic Information, Etoricoxib Manufacturing Base, Sales Area and Its Competitors
Table 140. Easton Biopharmaceuticals Etoricoxib Product Offered
Table 141. Easton Biopharmaceuticals Etoricoxib Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Easton Biopharmaceuticals Main Business
Table 143. Easton Biopharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Etoricoxib
Figure 2. Etoricoxib Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Etoricoxib Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Etoricoxib Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Etoricoxib Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 30 mg
Figure 10. Product Picture of 60 mg
Figure 11. Product Picture of 90 mg
Figure 12. Product Picture of 120 mg
Figure 13. Global Etoricoxib Sales Market Share by Type in 2021
Figure 14. Global Etoricoxib Revenue Market Share by Type (2017-2022)
Figure 15. Etoricoxib Consumed in Hospital
Figure 16. Global Etoricoxib Market: Hospital (2017-2022) & (K Units)
Figure 17. Etoricoxib Consumed in Pharmacy
Figure 18. Global Etoricoxib Market: Pharmacy (2017-2022) & (K Units)
Figure 19. Etoricoxib Consumed in Others
Figure 20. Global Etoricoxib Market: Others (2017-2022) & (K Units)
Figure 21. Global Etoricoxib Sales Market Share by Application (2017-2022)
Figure 22. Global Etoricoxib Revenue Market Share by Application in 2021
Figure 23. Etoricoxib Revenue Market by Company in 2021 ($ Million)
Figure 24. Global Etoricoxib Revenue Market Share by Company in 2021
Figure 25. Global Etoricoxib Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global Etoricoxib Revenue Market Share by Geographic Region in 2021
Figure 27. Global Etoricoxib Sales Market Share by Region (2017-2022)
Figure 28. Global Etoricoxib Revenue Market Share by Country/Region in 2021
Figure 29. Americas Etoricoxib Sales 2017-2022 (K Units)
Figure 30. Americas Etoricoxib Revenue 2017-2022 ($ Millions)
Figure 31. APAC Etoricoxib Sales 2017-2022 (K Units)
Figure 32. APAC Etoricoxib Revenue 2017-2022 ($ Millions)
Figure 33. Europe Etoricoxib Sales 2017-2022 (K Units)
Figure 34. Europe Etoricoxib Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa Etoricoxib Sales 2017-2022 (K Units)
Figure 36. Middle East & Africa Etoricoxib Revenue 2017-2022 ($ Millions)
Figure 37. Americas Etoricoxib Sales Market Share by Country in 2021
Figure 38. Americas Etoricoxib Revenue Market Share by Country in 2021
Figure 39. United States Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC Etoricoxib Sales Market Share by Region in 2021
Figure 44. APAC Etoricoxib Revenue Market Share by Regions in 2021
Figure 45. China Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 49. India Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe Etoricoxib Sales Market Share by Country in 2021
Figure 52. Europe Etoricoxib Revenue Market Share by Country in 2021
Figure 53. Germany Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 54. France Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa Etoricoxib Sales Market Share by Country in 2021
Figure 59. Middle East & Africa Etoricoxib Revenue Market Share by Country in 2021
Figure 60. Egypt Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country Etoricoxib Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of Etoricoxib in 2021
Figure 66. Manufacturing Process Analysis of Etoricoxib
Figure 67. Industry Chain Structure of Etoricoxib
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...